CO-DIAGNOSTICS, INC. (CODX) Gross margin 2017–2025
CO-DIAGNOSTICS, INC. (CODX) gross margin by fiscal year — reported gross profit divided by reported revenue.
64.3%FY2025 · since FY2017: 96.1% → 64.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 64.3% | -10.2 pp |
| FY2024 | 74.5% | +35.9 pp |
| FY2023 | 38.6% | -45.4 pp |
| FY2022 | 84.0% | -4.2 pp |
| FY2021 | 88.2% | +10.4 pp |
| FY2020 | 77.7% | +30.0 pp |
| FY2019 | 47.7% | -28.8 pp |
| FY2018 | 76.5% | -19.6 pp |
| FY2017 | 96.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CODX financial trends
CODX RevenueCODX Net incomeCODX Net marginCODX Gross profitCODX Operating incomeCODX Operating marginCODX Operating cash flowCODX Free cash flowCODX Capital expendituresCODX Return on equityCODX Stock buybacksCODX Dividends paidCODX Total assetsCODX Total liabilitiesCODX Shareholders’ equityCODX overview →